Evolution of the Average Target: Boston Scientific Corporation

Evolution of the Target Price: Boston Scientific Corporation

Changes in Analyst Recommendations: Boston Scientific Corporation

991a0fff3c13fd58f5e8c4ee7088a.vFMuX8OVmVYOtZb8wtYG3_Ib7yKfSgq96zjj_pWyEu0._jBAEKHf4WNHz9C_8-Vshrl-mXfeJ0fQo2uSndHKXJWFHlcKtdnUJnnArg~7e511762d4c552875b0f06fd6195365a
09-24 Wells Fargo Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Equalweight Rating MT
09-21 Oppenheimer Adjusts Price Target on Boston Scientific to $65 From $85, Maintains Outperform Rating MT
09-17 Boston Scientific Shares Fall After Citigroup Downgrade MT
09-17 Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57 MT
09-17 Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts Price Target to $50 From $57 MT
09-14 Bernstein Adjusts Price Target on Boston Scientific to $60 From $72, Keeps Outperform Rating MT
09-10 Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating MT
09-08 Boston Scientific Cyberattack Could Extend Rebound Timeline, Truist Says MT
07-31 Argus Downgrades Boston Scientific to Hold From Buy MT
07-30 Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says MT
07-30 Leerink Partners Adjusts Boston Scientific Price Target to $60 From $74, Maintains Outperform Rating MT
07-30 Wells Fargo Adjusts Boston Scientific Price Target to $50 From $55, Maintains Equal Weight Rating MT
07-30 Bernstein Adjusts Boston Scientific Price Target to $72 From $76, Maintains Outperform Rating MT
07-30 JPMorgan Adjusts Boston Scientific Price Target to $56 From $80, Maintains Overweight Rating MT
07-30 UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating MT
07-30 Baird Adjusts Price Target on Boston Scientific to $53 From $64, Maintains Outperform Rating MT
07-30 TD Cowen Adjusts Price Target on Boston Scientific to $56 From $61, Maintains Buy Rating MT
07-30 Jefferies Adjusts Price Target on Boston Scientific to $60 From $67, Maintains Buy Rating MT
07-30 Canaccord Genuity Adjusts Price Target on Boston Scientific to $66 From $70, Maintains Buy Rating MT
07-30 Mizuho Adjusts Price Target on Boston Scientific to $60 From $70, Maintains Outperform Rating MT
07-30 Raymond James Adjusts Price Target on Boston Scientific to $57 From $78, Maintains Outperform Rating MT
07-30 RBC Cuts Price Target on Boston Scientific to $70 From $85, Keeps Outperform Rating MT
07-30 Rothschild & Co Redburn Adjusts Price Target on Boston Scientific to $78 From $106, Maintains Buy Rating MT
07-30 Deutsche Bank Adjusts Boston Scientific PT to $60 From $75, Maintains Buy Rating MT
07-30 The Fed Gets a Better Inflation Number Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-3.29%
+4.92%
+17.14%
+39.75%
+16.96%
+1.68%
+19.89%
+4.15%
+1.67%
Average +11.43%
Weighted average by Cap. +8.33%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
43.65USD
Average target price
61.00USD
Spread / Average Target
+39.75%
High Price Target
94.00USD
Spread / Highest target
+115.35%
Low Price Target
44.00USD
Spread / Lowest Target
+0.80%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. BSX Stock
  4. BSX Stock
  5. Consensus Boston Scientific Corporation